254 related articles for article (PubMed ID: 9112674)
21. Inhibition of platelet-mediated clot retraction by integrin antagonists.
Hantgan RR; Mousa SA
Thromb Res; 1998 Mar; 89(6):271-9. PubMed ID: 9669749
[TBL] [Abstract][Full Text] [Related]
22. A method for the quantitative assessment of platelet-induced clot retraction and clot strength in fresh and stored platelets.
Reid TJ; Snider R; Hartman K; Greilich PE; Carr ME; Alving BM
Vox Sang; 1998; 75(4):270-7. PubMed ID: 9873262
[TBL] [Abstract][Full Text] [Related]
23. The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction.
Rooney MM; Farrell DH; van Hemel BM; de Groot PG; Lord ST
Blood; 1998 Oct; 92(7):2374-81. PubMed ID: 9746777
[TBL] [Abstract][Full Text] [Related]
24. [Structure-functional analysis of peptide P3 identical to gamma370-383 binding sites with integrin alphaIIbbeta3 in gammaC-domain of fibrinogen].
Podol'nikova NP; Volkov HL; Uharova TP
Ukr Biokhim Zh (1999); 2003; 75(6):99-105. PubMed ID: 15143525
[TBL] [Abstract][Full Text] [Related]
25. Thrombin binding to GPIbalpha induces platelet aggregation and fibrin clot retraction supported by resting alphaIIbbeta3 interaction with polymerized fibrin.
Dubois C; Steiner B; Kieffer N; Reigner SC
Thromb Haemost; 2003 May; 89(5):853-65. PubMed ID: 12719784
[TBL] [Abstract][Full Text] [Related]
26. Tyrosine kinases regulate the cytoskeletal attachment of integrin alpha IIb beta 3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin polymers.
Schoenwaelder SM; Jackson SP; Yuan Y; Teasdale MS; Salem HH; Mitchell CA
J Biol Chem; 1994 Dec; 269(51):32479-87. PubMed ID: 7798249
[TBL] [Abstract][Full Text] [Related]
27. Binding of anti-actin autoantibodies to platelets.
Bouvier CA; Gabbiani G; Ryan GB; Badonnel MC; Majno G; Lüscher EF
Thromb Haemost; 1977 Apr; 37(2):321-8. PubMed ID: 406689
[TBL] [Abstract][Full Text] [Related]
28. Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin alphaIIbbeta3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots.
Schoenwaelder SM; Yuan Y; Cooray P; Salem HH; Jackson SP
J Biol Chem; 1997 Jan; 272(3):1694-702. PubMed ID: 8999848
[TBL] [Abstract][Full Text] [Related]
29. Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts.
Kasahara K; Kaneda M; Miki T; Iida K; Sekino-Suzuki N; Kawashima I; Suzuki H; Shimonaka M; Arai M; Ohno-Iwashita Y; Kojima S; Abe M; Kobayashi T; Okazaki T; Souri M; Ichinose A; Yamamoto N
Blood; 2013 Nov; 122(19):3340-8. PubMed ID: 24002447
[TBL] [Abstract][Full Text] [Related]
30. Disulfide bond exchanges in integrins αIIbβ3 and αvβ3 are required for activation and post-ligation signaling during clot retraction.
Mor-Cohen R; Rosenberg N; Averbukh Y; Seligsohn U; Lahav J
Thromb Res; 2014 May; 133(5):826-36. PubMed ID: 24560420
[TBL] [Abstract][Full Text] [Related]
31. Phosphoinositide 3-kinase p110 beta regulates integrin alpha IIb beta 3 avidity and the cellular transmission of contractile forces.
Schoenwaelder SM; Ono A; Nesbitt WS; Lim J; Jarman K; Jackson SP
J Biol Chem; 2010 Jan; 285(4):2886-96. PubMed ID: 19940148
[TBL] [Abstract][Full Text] [Related]
32. A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects.
Kiyoi T; Tomiyama Y; Honda S; Tadokoro S; Arai M; Kashiwagi H; Kosugi S; Kato H; Kurata Y; Matsuzawa Y
Blood; 2003 May; 101(9):3485-91. PubMed ID: 12506038
[TBL] [Abstract][Full Text] [Related]
33. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.
Braaten JV; Jerome WG; Hantgan RR
Blood; 1994 Feb; 83(4):982-93. PubMed ID: 8111066
[TBL] [Abstract][Full Text] [Related]
34. EDTA-induced changes in platelet structure and function: clot retraction.
White JG
Platelets; 2000 Feb; 11(1):49-55. PubMed ID: 10938882
[TBL] [Abstract][Full Text] [Related]
35. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
Taylor FB; Müller-Eberhard HJ
J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
[TBL] [Abstract][Full Text] [Related]
36. The integrin alpha IIb/beta 3 in human platelet signal transduction.
Payrastre B; Missy K; Trumel C; Bodin S; Plantavid M; Chap H
Biochem Pharmacol; 2000 Oct; 60(8):1069-74. PubMed ID: 11007943
[TBL] [Abstract][Full Text] [Related]
37. Role of the fibrinogen gamma-chain sequence gamma316-322 in platelet-mediated clot retraction.
Remijn JA; IJsseldijk MJ; De Groot PG
J Thromb Haemost; 2003 Oct; 1(10):2245-6. PubMed ID: 14521614
[No Abstract] [Full Text] [Related]
38. Reptilase clot retraction test. (Its cofactors and relation to other platelet functions).
Kubisz P; Suranova J
Pathol Biol (Paris); 1975 Apr; 23(4):269-75. PubMed ID: 1097991
[TBL] [Abstract][Full Text] [Related]
39. Involvement of Src kinases and PLCgamma2 in clot retraction.
Suzuki-Inoue K; Hughes CE; Inoue O; Kaneko M; Cuyun-Lira O; Takafuta T; Watson SP; Ozaki Y
Thromb Res; 2007; 120(2):251-8. PubMed ID: 17055557
[TBL] [Abstract][Full Text] [Related]
40. The effect of a monoclonal antibody specific for human platelet GPIIb/IIIa (TP80) on platelet function.
Higashihara M; Maeda H; Ohashi T; Oka H; Kume S
Nihon Ketsueki Gakkai Zasshi; 1987 Jul; 50(4):926-35. PubMed ID: 3687337
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
